Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TTRX stock hub

Turn Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TTRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

112.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TTRX

In the news

Latest news · TTRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-141.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-168.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TTRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

USD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002023016
Company name	Turn Therapeutics Inc.
Country	United States
Country code	US
Cusip	90021W105
Employees	2
Employees Change	-2%
Employees Change Percent	-50
Enterprise value	$107.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US90021W1053
Last refreshed	2026-05-10
Market cap	$112.9M
Market cap category	Micro-Cap
Price	$3.79
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	TTRX
Website	https://turntherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.83%
P/B ratio	23.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-496,948
Net Income	$-3.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.6M
ROA	-55.9
ROCE	-103.2
ROE	-141.7
ROIC	-168.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$12.2M
Cash	$5.1M
Current Assets	$5.2M
Current Liabilities	$6M
Debt	$80,376
Debt Equity	$0.02
Equity	$4.7M
Liabilities	$7.5M
Long Term Assets	$7M
Long Term Liabilities	$1.5M
Net Cash	$5M
Net Cash By Market Cap	$4.43
Net Cash Growth	564.72%
Net Debt Equity	$-1.07
Tangible Book Value	$3.8M
Tangible Book Value Per Share	$0.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Net Working Capital	$-5.8M
Quick ratio	0.85
Working Capital	$-806,980

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.03%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	3.49
All Time High	26.5
All Time High Change	-85.7%
All Time High Date	2025-10-09
All Time Low	2.57
All Time Low Change	47.47%
All Time Low Date	2025-11-20
ATR	0.21
Beta1y	0.01
Ch YTD	-3.81
High	3.79
High52	26.5
High52 Date	2025-10-09
High52ch	-85.7%
Low	3.66
Low52	2.57
Low52 Date	2025-11-20
Low52ch	47.47%
Ma50ch	8.5%
Premarket Change Percent	-3.26
Premarket Price	$3.67
Premarket Volume	706
RSI	60.92
RSI Monthly	0
RSI Weekly	37.21
Sharpe ratio	-0.43x
Sortino ratio	-0.6
Total Return	-4.03%
Tr YTD	-3.81
Tr1m	12.8%
Tr1w	-0.27%
Tr3m	-1.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.02
Operating Income	$-6.4M
Price target	$8
Price Target Change	$111

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,128,428%
Float Percent	37.36%
Shares Insiders	57.78%
Shares Institutions	1.69%
Shares Out	29,788,040
Shares Qo Q	1.61%
Shares Yo Y	4.03%
Short Float	0.54%
Short Ratio	2.21
Short Shares	0.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	22,019.3x
Bv Per Share	0.16
Ch1m	12.8
Ch1w	-0.27
Ch3m	-1.56
Ch6m	-5.72
Change	-0.13%
Change From Open	3.55
Close	3.8
Days Gap	-3.56
Depreciation Amortization	52,746
Dollar Volume	111,794.5
Earnings Date	2026-05-31
Earnings Time	amc
EBIT	$-6.4M
EBITDA	$-6.3M
EPS	$-0.12
F Score	1
Financing CF	6,919,432
Fiscal Year End	December
Founded	2,015
Investing CF	-152,986
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma20	3.56
Ma20ch	6.49%
Net CF	4,203,545
Next Earnings Date	2026-05-31
Open	3.66
Optionable	No
Position In Range	99.92
Post Close	3.79
Postmarket Change Percent	-1.84
Postmarket Price	$3.72
Ppne	78,620
Pre Close	3.8
Price Date	2026-05-08
Ptbv Ratio	29.99
Relative Volume	1.34x
Share Based Comp	669,245
Tr6m	-5.72%
Us State	California
Volume	29,498

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TTRX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns TTRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.7%

Float: +37.4% of shares outstanding

Insider ownership

+57.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TTRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.9

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TTRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TTRX stock rating?

Turn Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TTRX analysis?

The full report lives at /stocks/TTRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TTRX?

The latest report frames TTRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TTRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.